Experimental models of osteoarthritis: Usefulness in the development of disease-modifying osteoarthritis drugs/agents

Jean Pierre Pelletier, Christelle Boileau, Roy D. Altman, Johanne Martel-Pelletier

Research output: Contribution to journalReview article

8 Scopus citations

Abstract

This work aims at reviewing the experimental animal models capable of reproducing osteoarthritis (OA) changes as seen in humans. Relevant studies in which compounds/agents have been tested for potential effect as disease-modifying OA drugs in large-to-small OA animal models are reviewed. Special attention is given to studies in which compounds were investigated in a translational fashion: from preclinical models to humans. This review is by no means comprehensive, but does cover the majority of therapeutics and disease-modifying OA drugs/agents tested in OA animal models. Findings from these studies may provide insight into the suitability of these models for the evaluation of therapeutic agents that could be effective in humans.

Original languageEnglish (US)
Pages (from-to)621-634
Number of pages14
JournalTherapy
Volume7
Issue number6
DOIs
StatePublished - Nov 1 2010

Keywords

  • animal models
  • disease-modifying osteoarthritis drug
  • osteoarthritis
  • therapeutic agents
  • therapeutic targets

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Experimental models of osteoarthritis: Usefulness in the development of disease-modifying osteoarthritis drugs/agents'. Together they form a unique fingerprint.

  • Cite this